Analyst Ratings for Rapport Therapeutics (RAPP)
RAPP Rating Summary
RAPP Price Target Summary
- Highest: $80.00 (Citizens)
- Lowest: $46.00 (Wells Fargo)
- Average: $61.46
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$61.46 (+122.9%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/15/2026 | Wolfe Research | Rudy Li | New Coverage | Outperform (N/A) |
50.00 (N/A) |
28.33 (27.57) |
-2.68% | Details |
| 10/14/2026 | UBS | N/A | New Coverage | Buy (N/A) |
71.00 (N/A) |
28.99 (27.57) |
-4.9% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
